Haemonetics HAE Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Haemonetics’s reported figures.
Based on the most recent quarter.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's debt-to-equity?
- Haemonetics (HAE) reported debt-to-equity of 1.6× in Q1 2026.
- How has Haemonetics's debt-to-equity changed year-over-year?
- Haemonetics's debt-to-equity increased by 2.4% year-over-year, from 1.6× to 1.6×.
- What is the long-term trend for Haemonetics's debt-to-equity?
- Over 5 years (2021 to 2026), Haemonetics's debt-to-equity has grown at a 8.5% compound annual growth rate (CAGR), from 1.1× to 1.6×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.